-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Teva Pharmaceutical Industries Ltd quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2010 to 2023.
- Teva Pharmaceutical Industries Ltd Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 1.13B shares, a 0.18% decline year-over-year.
- Teva Pharmaceutical Industries Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.12B shares, a 0.81% increase from 2022.
- Teva Pharmaceutical Industries Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.11B shares, a 0.27% increase from 2021.
- Teva Pharmaceutical Industries Ltd annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 1.11B shares, a 1.1% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)